250 related articles for article (PubMed ID: 27260863)
1. Hidden wholesale: The drug diffusing capacity of online drug cryptomarkets.
Aldridge J; Décary-Hétu D
Int J Drug Policy; 2016 Sep; 35():7-15. PubMed ID: 27260863
[TBL] [Abstract][Full Text] [Related]
2. Comparing cryptomarkets for drugs. A characterisation of sellers and buyers over time.
Tzanetakis M
Int J Drug Policy; 2018 Jun; 56():176-186. PubMed ID: 29449105
[TBL] [Abstract][Full Text] [Related]
3. Delivery dilemmas: How drug cryptomarket users identify and seek to reduce their risk of detection by law enforcement.
Aldridge J; Askew R
Int J Drug Policy; 2017 Mar; 41():101-109. PubMed ID: 28089207
[TBL] [Abstract][Full Text] [Related]
4. Going international? Risk taking by cryptomarket drug vendors.
Décary-Hétu D; Paquet-Clouston M; Aldridge J
Int J Drug Policy; 2016 Sep; 35():69-76. PubMed ID: 27453145
[TBL] [Abstract][Full Text] [Related]
5. Safer scoring? Cryptomarkets, social supply and drug market violence.
Barratt MJ; Ferris JA; Winstock AR
Int J Drug Policy; 2016 Sep; 35():24-31. PubMed ID: 27241015
[TBL] [Abstract][Full Text] [Related]
6. The transparency paradox. Building trust, resolving disputes and optimising logistics on conventional and online drugs markets.
Tzanetakis M; Kamphausen G; Werse B; von Laufenberg R
Int J Drug Policy; 2016 Sep; 35():58-68. PubMed ID: 26809972
[TBL] [Abstract][Full Text] [Related]
7. Forensic drug intelligence and the rise of cryptomarkets. Part II: Combination of data from the physical and virtual markets.
Morelato M; Broséus J; De Grazia A; Tahtouh M; Esseiva P; Roux C
Forensic Sci Int; 2018 Jul; 288():201-210. PubMed ID: 29763810
[TBL] [Abstract][Full Text] [Related]
8. Who sells what? Country specific differences in substance availability on the Agora cryptomarket.
Van Buskirk J; Naicker S; Roxburgh A; Bruno R; Burns L
Int J Drug Policy; 2016 Sep; 35():16-23. PubMed ID: 27520115
[TBL] [Abstract][Full Text] [Related]
9. 'What if you live on top of a bakery and you like cakes?'-Drug use and harm trajectories before, during and after the emergence of Silk Road.
Barratt MJ; Lenton S; Maddox A; Allen M
Int J Drug Policy; 2016 Sep; 35():50-7. PubMed ID: 27157539
[TBL] [Abstract][Full Text] [Related]
10. New psychoactive substances (NPS) on cryptomarket fora: An exploratory study of characteristics of forum activity between NPS buyers and vendors.
Van Hout MC; Hearne E
Int J Drug Policy; 2017 Feb; 40():102-110. PubMed ID: 28027812
[TBL] [Abstract][Full Text] [Related]
11. Offline constraints in online drug marketplaces: An exploratory analysis of a cryptomarket trade network.
Norbutas L
Int J Drug Policy; 2018 Jun; 56():92-100. PubMed ID: 29621742
[TBL] [Abstract][Full Text] [Related]
12. Assessing market competition and vendors' size and scope on AlphaBay.
Paquet-Clouston M; Décary-Hétu D; Morselli C
Int J Drug Policy; 2018 Apr; 54():87-98. PubMed ID: 29414490
[TBL] [Abstract][Full Text] [Related]
13. Characterising dark net marketplace purchasers in a sample of regular psychostimulant users.
Van Buskirk J; Roxburgh A; Bruno R; Naicker S; Lenton S; Sutherland R; Whittaker E; Sindicich N; Matthews A; Butler K; Burns L
Int J Drug Policy; 2016 Sep; 35():32-7. PubMed ID: 26872846
[TBL] [Abstract][Full Text] [Related]
14. Silicon to syringe: Cryptomarkets and disruptive innovation in opioid supply chains.
Gilbert M; Dasgupta N
Int J Drug Policy; 2017 Aug; 46():160-167. PubMed ID: 28735772
[TBL] [Abstract][Full Text] [Related]
15. 'Nice people doing shady things': Drugs and the morality of exchange in the darknet cryptomarkets.
Masson K; Bancroft A
Int J Drug Policy; 2018 Aug; 58():78-84. PubMed ID: 29870962
[TBL] [Abstract][Full Text] [Related]
16. Nonmedical prescription psychiatric drug use and the darknet: A cryptomarket analysis.
Cunliffe J; Décary-Hêtu D; Pollak TA
Int J Drug Policy; 2019 Nov; 73():263-272. PubMed ID: 30772109
[TBL] [Abstract][Full Text] [Related]
17. An island apart? Risks and prices in the Australian cryptomarket drug trade.
Cunliffe J; Martin J; Décary-Hétu D; Aldridge J
Int J Drug Policy; 2017 Dec; 50():64-73. PubMed ID: 29055855
[TBL] [Abstract][Full Text] [Related]
18. Mixing politics and crime - The prevalence and decline of political discourse on the cryptomarket.
Munksgaard R; Demant J
Int J Drug Policy; 2016 Sep; 35():77-83. PubMed ID: 27424175
[TBL] [Abstract][Full Text] [Related]
19. Should we smoke it for you as well? An ethnographic analysis of a drug cryptomarket environment.
Kowalski M; Hooker C; Barratt MJ
Int J Drug Policy; 2019 Nov; 73():245-254. PubMed ID: 31054880
[TBL] [Abstract][Full Text] [Related]
20. Forensic drug intelligence and the rise of cryptomarkets. Part I: Studying the Australian virtual market.
Broséus J; Morelato M; Tahtouh M; Roux C
Forensic Sci Int; 2017 Oct; 279():288-301. PubMed ID: 28927690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
